Novavax
NVAX
#5751
Rank
HK$8.74 B
Marketcap
HK$53.79
Share price
0.73%
Change (1 day)
-16.75%
Change (1 year)

Novavax (NVAX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$10.40 Billion

According to Novavax's latest financial reports the company's total liabilities are HK$10.40 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Novavax - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$16.95 B-13.65%
2023-12-31HK$19.63 B-13.11%
2022-12-31HK$22.60 B-1.02%
2021-12-31HK$22.83 B208.35%
2020-12-31HK$7.40 B164.88%
2019-12-31HK$2.79 B-5.03%
2018-12-31HK$2.94 B-6.79%
2017-12-31HK$3.15 B1.86%
2016-12-31HK$3.10 B328.46%
2015-12-31HK$0.72 B101.15%
2014-12-31HK$0.35 B45.49%
2013-12-31HK$0.24 B44.33%
2012-12-31HK$0.17 B73.33%
2011-12-31HK$98.84 M-19.58%
2010-12-31HK$0.12 B1.27%
2009-12-31HK$0.12 B-49.56%
2008-12-31HK$0.24 B9.33%
2007-12-31HK$0.22 B1.51%
2006-12-31HK$0.21 B-19.48%
2005-12-31HK$0.26 B-22.5%
2004-12-31HK$0.34 B-7.03%
2003-12-31HK$0.37 B-3.05%
2002-12-31HK$0.38 B24.77%
2001-12-31HK$0.30 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Agenus
AGEN
HK$4.00 B-61.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$16.91 B 62.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$6.83 B-34.27%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
HK$6.49 B-37.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$533.11 B 5,023.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
HK$900.14 B 8,551.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$486.81 B 4,578.95%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
HK$10.17 M-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$477.06 B 4,485.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
HK$0.38 B-96.25%๐Ÿ‡บ๐Ÿ‡ธ USA